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DObjective: This study describes echocardiographic allograft valve function over time in a cohort of patients who
were prospectively followed after allograft aortic valve or root replacement, illustrating the use of longitudinal
data analysis for assessing valve function over time.
Methods: Serial, standardized echocardiographic measurements of aortic regurgitation, aortic gradient, annulus
diameter, left ventricular outflow tract diameter, and aortic diameter in 301 hospital survivors (mean age, 46
years; range, 16-83 years) after allograft aortic valve (N ¼ 77) or root (N ¼ 224) replacement were analyzed
using nonlinear longitudinal models.
Results: Aortic regurgitation increased over time. At 15 years, 41% of patients had at least moderate aortic
regurgitation. Younger patient age and subcoronary implantation technique were associated with increased
aortic regurgitation. Aortic gradient increased over time (from 9.4 mm Hg at 6 months to 21.3 mm Hg at 15
years); both initial and increase in aortic gradient were greater in younger patients and after subcoronary implan-
tation technique. Annulus diameter slightly increased (from 21.9 mm at 6 months to 22.4 mm at 15 years),
whereas aortic diameter slightly decreased over time (from 34.3 mm at 6 months to 32.7 mm at 15 years).
Left ventricular outflow tract diameter remained constant at 22 mm. Younger patients in the subcoronary
implantation group had a larger annulus diameter.
Conclusions: Both aortic regurgitation and stenosis increase over time after allograft aortic valve or root
replacement. Younger patient age and use of the subcoronary implantation technique are associated with
increased regurgitation and stenosis. The use of nonlinear longitudinal models allows for an insightful analysis
of allograft valve function over time. (J Thorac Cardiovasc Surg 2014;148:1921-8)See related commentary on pages 1929-30.Supplemental material is available online.
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The Journal of Thoracic and Cartoday there is increasing evidence that allograft durability
is comparable to other biological valve substitutes.2,3
Currently, their application is mainly in patients with
complex cardiac and aortic root pathology in the setting of
an active endocarditis.
The assessment of allograft valve performance over time
is difficult. Echocardiographic measurements obtained over
time after allograft implantation are usually dichotomized
by using time-to-event methods and are reported as, for
example, freedom from aortic regurgitation (AR) grade
1þ or 3þ at a certain follow-up time.4,5 Dichotomization
of longitudinal data is often inappropriate because it leads
to loss of information and incorrect statistical inferences.
The 2008 guidelines for reporting mortality and morbidity
after cardiac valvular interventions6 propose the use of lon-
gitudinal data analysis for series of assessments, such as
repeated echocardiographic measurements of valve func-
tion to estimate its average temporal pattern and variability
in a group of patients. Repeated measurement data have
several important characteristics that are taken into account
by longitudinal analyses methods but that are not taken into
account by time-to-event methods.
The aim of this study is to describe echocardiographic
allograft valve function over time in a prospective cohortdiovascular Surgery c Volume 148, Number 5 1921
Abbreviations and Acronyms
AR ¼ aortic regurgitation
LVOT ¼ left ventricular outflow tract
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Dof patients who underwent allograft aortic valve or root
replacement. This will be done by using and illustrating
the use of advanced longitudinal data analysis techniques.
METHODS
Patients
Between April 1987 and September 2010, a total of 347 patients under-
went 356 aortic valve or root replacements with an allograft at the Erasmus
University Medical Center, Rotterdam, The Netherlands (Table 1). After
these 356 procedures, 301 hospital survivors had 1 or more standardized
echocardiographic examinations. The small number of patients with repeat
operations (n¼ 9) were considered as independent patients because the pri-
mary focus of this study was allograft valve function over time. Approval
from the institutional review board (No. EMC00-813) was obtained for this
prospective follow-up study, and all patients provided informed consent.
The clinical outcome of the total cohort has been reported.3
Surgical Procedures
Surgical procedures were performed through a median sternotomy on
cardiopulmonary bypass with moderate hypothermia (Table 2). Crystalloid
cardioplegia and topical cooling were used for myocardial protection. Deep
hypothermia and circulatory arrest were used in 32 patients with ascending
aorta or arch pathology. Early in our experience, the subcoronary technique
was used; since 1998, root replacement has become the technique of choice.
Of the 356 procedures, subcoronary allograft implantation was performed
in 94 patients7 and root replacement was performed as a freestanding root
with reimplantation of the coronary arteries in 262 patients. From these pa-
tients, 1 or more standardized echocardiographic examinations were avail-
able for 77 patients who underwent the subcoronary allograft implantation
technique and 224 patients who underwent the root replacement technique.
Echocardiographic Follow-up
Serial, standardized echocardiography has been performed at Erasmus
University Medical Center in all patients aged 16 years or more who
received human tissue valves since 1987. Postoperative echocardiographic
examinations were scheduled at 6 months, at 1 year, and thereafter once
every 2 years.8 A detailed description of the echocardiographic follow-
up can be found in the Online Methods Supplement.
Statistical Analyses
All the analyses were performed using SAS9.1 (SAS Institute Inc, Cary,
NC), and some plots were created using S-Plus6.2 statistical software
(Insightful Corp, Lucent Technologies Inc, Palo Alto, Calif).
Analyses of clinical data
Presentation. Continuous variables are summarized as mean  stan-
dard deviation, and comparison was done using the unpaired t test unless
the data were not normally distributed (Kolmogorov–Smirnov test); in
these instances, we used the Mann–Whitney U test for comparison. Cate-
goric data are presented as proportions, and comparison was done using
the chi-square test or Fisher exact test where appropriate. All tests were
2-sided, with an alpha level of 0.05.
Survival analyses. Overall nonparametric survival estimates were ob-
tained by the method of Kaplan–Meier. A parametric method was used to
resolve the number of phases of instantaneous risk of death (hazard func-
tion) and to estimate the shaping parameters.9 To identify risk factors for1922 The Journal of Thoracic and Cardiovascular Surdeath, multivariable analyses were performed in the multiphase hazard
function domain.
In the multivariable analysis, factors modulating both hazard phases
were considered simultaneously. Early risk factors are those found to in-
crease the area beneath the early decreasing hazard phase, and late risk fac-
tors are those that increase the level of underlying increasing hazard.
Within each hazard phase, we assume proportional hazards, but because
the 2 hazard phases are operative across all time, this produces overall a
nonproportional hazard model. Such a model is particularly appropriate
for strongly time-varying hazard, as is evident for these events.
Reoperation analyses. Reoperation and multivariable analyses of
patients who underwent reoperation were performed in a similar method
used to study survival.
Analyses of echocardiographic data
Categoric echocardiographic measurement. To assess the tem-
poral trend of likelihood of AR grades over time after surgery, follow-up
transthoracic echocardiograms were analyzed longitudinally for percent-
ages of patients in each AR grade across time. Because there is no practical
method for continuous heart valve function assessment, a nonlinear cumu-
lative logitmixedmodel10,11was used to resolve a number of time phases on
cumulative odds domain to form a temporal decomposition model and to
estimate the shaping parameters at each phase. A longitudinal cumulative
logistic mixed model12,13 for repeated measurements (SAS PROC
NLMIXED; SAS Institute Inc) was used to implement the temporal
decomposition model and to estimate the patient-specific probabilities for
being in each AR grade. These patient-specific estimates were then aver-
aged to obtain the percentages of patients (prevalence) in each grade. These
methods were applied because they simultaneously solve multiple chal-
lenges of continuously collected echocardiographic data (eg, repeatedmea-
surements for each patient, variable time of recording, censoring by death).
Continuous echocardiographic measurement. To assess the
temporal trend of aortic valve gradient, annulus diameter, aortic diameter,
and left ventricular outflow tract (LVOT) diameter over time after surgery,
follow-up transthoracic echocardiographic measurements were analyzed
longitudinally for change in mean response across time.14 A nonlinear lon-
gitudinal mixed model regression12,13 (SAS PROC NLMIXED; SAS
Institute Inc) was used to analyze these continuous repeatedmeasurements.RESULTS
Perioperative Details
Table 2 shows the perioperative details. There were 4 pa-
tients (all root replacements) who required coronary artery
bypass grafting because of problems related to the reinser-
tion of the coronary arteries. The detailed causes were as
follows: In 1 patient the left coronary artery button was
too small, causing coronary ostium stenosis; 1 patient had
annular calcifications extending up to the right coronary
ostium that was thin-layered and ruptured after reimplanta-
tion; 1 patient had right ventricular dysfunction due to kink-
ing of the reimplanted right coronary artery; and in 1
patient, the attending surgeon made the decision to perform
coronary artery bypass grafting on the basis of his observa-
tions of suboptimal coronary flow causing malperfusion of
both the right and left coronary arteries. Hospital mortality
was 5.9% (21/356 surgical procedures).Clinical Follow-up
During follow-up, another 79 patients died (2.1%/patient
year): Deaths were not valve related and were noncardiac ingery c November 2014
TABLE 1. Baseline characteristics of patients used for clinical follow-up (total cohort) and echocardiographic follow-up (echocardiography
cohort)
Characteristic
Total cohort
(n ¼ 356)
Echocardiography
cohort (n ¼ 301)
Subcoronary
(n ¼ 77/301)
Root replacement
(n ¼ 224/301)
Subcoronary vs
root replacement
n (%)*
No. (%) or
mean ± SD n (%)*
No. (%) or
mean ± SD
No. (%) or
mean ± SD
No. (%) or
mean ± SD P value
Demography
Age (y) 356 (100) 44.4  16.4 301 (100) 45.6  14.5 46  14.1 45.4  14.7 .9
Gender 356 (100) 301 (100) .88
Male 251 (71) 217 (72) 55 (71) 162 (72)
Female 105 (29) 84 (28) 22 (29) 62 (28)
BSA (m2) 356 (100) 1.89  0.26 301 (100) 1.93  0.2 1.91  0.19 1.94  0.2 .5
Creatinine (mmol/L) 354 (99) 103  85.2 300 (100) 97.8  62.4 109  101 93.8  41.5 .033
Symptoms
NYHA functional class 355 (100) 300 (100) <.001
I 92 (26) 83 (28) 11 (14) 72 (32)
II 95 (27) 81 (27) 21 (27) 60 (27)
III 105 (30) 89 (30) 38 (49) 51 (23)
IV 63 (18) 47 (16) 7 (9.1) 40 (18)
Timing of surgery 354 (99) 299 (99) .007
Surgery within 24 h 39 (11) 30 (10) 2 (2.6) 28 (13)
Surgery within the same
hospitalization
101 (29) 84 (28) 17 (22) 67 (30)
Elective surgery 214 (60) 185 (62) 58 (75) 127 (57)
Ventilation support 356 (100) 21 (5.9) 301 (100) 14 (4.7) 0 (0) 14 (6.3) .025
Aortic valve 355 (100) 289 (96) .092
Pure aortic stenosis 68 (19.2) 59 (20) 21 (27) 38 (17)
Pure AR 206 (58.0) 175 (58) 43 (56) 132 (59)
Mixed AR/stenosis 65 (18.3) 55 (18) 13 (17) 42 (19)
Noncardiac comorbidity
DM 356 (100) 12 (3.4) 301 (100) 8 (2.7) 3 (3.9) 5 (2.2) .43
Hypertension 356 (100) 51 (14) 301 (100) 40 (13) 10 (13) 30 (13) .93
Renal disease 353 (99) 12 (3.4) 298 (99) 5 (1.7) 3 (3.9) 2 (0.9) .078
CVA 356 (100) 19 (5.3) 301 (100) 16 (5.3) 7 (9.1) 9 (4) .087
Rhythm 354 (99) 300 (100) .4
Sinus rhythm 326 (92) 284 (95) 71 (92) 213 (96)
Atrial fibrillation 11 (3.1) 6 (2) 2 (2.6) 4 (1.8)
Heart block 9 (2.5) 7 (2.3) 2 (2.6) 5 (2.2)
Other rhythm 8 (2.3) 3 (1) 2 (2.6) 1 (0.45)
Left ventricular function 348 (98) 298 (99) .54
Good 260 (75) 222 (74) 59 (77) 163 (74)
Impaired 64 (18) 55 (18) 14 (18) 41 (19)
Moderate 7 (2) 6 (2) 0 (0) 6 (2.7)
Poor 17 (4.9) 15 (5) 4 (5.2) 11 (5)
AR, Aortic regurgitation; BSA, body surface area; CVA, cerebrovascular accident; DM, diabetes mellitus; NYHA, New York Heart Association; SD, standard deviation. *Number
of patients with data available.
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were valve-related in 23 patients (sudden unexpected unex-
plained death in 15, intracranial bleeding in 1, endocarditis
in 4, and structural valve deterioration in 3 [1 after reopera-
tion and 2 due to heart failure]), and of unknown cause in 12
patients. The overall parametric estimates of survival at 1
year, 5 years, 10 years, and 15 years were 93%, 86%,
78%, and 65%, respectively (Figures 1 and E1). Risk
factors associated with early and late death are shown in
Table 3.The Journal of Thoracic and CarDuring follow-up, 103 patients required a reoperation; of
these operations, 81 were performed for structural valve
deterioration, 18 were performed for nonstructural valve
failure, and 4 were performed for allograft endocarditis.
After taking the competing occurrence of death into ac-
count, the overall parametric estimates of freedom from re-
operation at 1 year, 5 years, 10 years, and 15 years were
97%, 92%, 80%, and 56%, respectively (Figures 1 and
E1). Risk factors associated with early and late
reoperation are shown in Table 3.diovascular Surgery c Volume 148, Number 5 1923
TABLE 2. Perioperative characteristics of patients used for clinical follow-up (total cohort) and echocardiographic follow-up (echocardiography
cohort)
Characteristic
Total cohort
(n ¼ 356)
Echocardiography
cohort (n ¼ 301)
Subcoronary
(n ¼ 77/301)
Root replacement
(n ¼ 224/301)
Subcoronary vs
root replacement
n (%)*
No. (%) or
mean ± SD n (%)*
No. (%) or
mean ± SD P value
No. (%) or
mean ± SD P value
Female donor gender 345 (97) 130 (38) 294 (98) 109 (37) 24 (32) 85 (39) .34
Allograft diameter 353 (99) 22.7  2.05 300 (100) 22.7  1.92 23.3  2.13 22.5  1.82 .007
Procedure
Perfusion time 355 (99) 197  77.6 300 (100) 194  76.8 177  41.7 200  85 .21
Crossclamp time 355 (99) 141  57.8 300 (100) 141  58.7 134  31.7 143  65.4 .77
Circulatory arrest 353 (99) 3.55  14.5 300 (100) 3.79  15.2 0  0 5.1  17.4 <.001
Type of allograft implanted 355 (100) 300 (100) .31
Aortic 297 298 (99%) 76 (99) 222 (99)
Pulmonary 6 2 (1%) 1 (1) 1 (1)
Allograft preservation method 356 (100) 301 (100) .1
Cryopreserved 349 (98) 298 (99) 75 (97.4) 223 (99.6)
Fresh 7 (2) 3 (1) 2 (2.6) 1 (0.4)
Concomitant procedures 299 (99) <.001
CABG 354 (99) 34 (9.6) 30 (10) 10 (13) 20 (9)
Mitral valve surgery 354 (99) 25 (7.1) 17 (5.7) 7 (9.1) 10 (4.5)
Extended root surgery 354 (99) 48 (14) 44 (15) 0 (0) 44 (20)
Other procedures 354 (99) 65 (18) 50 (17) 7 (9.1) 43 (19)
Rhythm at discharge 345 (97) 300 (100) .16
Sinus rhythm 305 (88) 276 (92) 68 (88) 208 (93)
Atrial fibrillation 11 (3.2) 11 (3.7) 5 (6.5) 6 (2.7)
Heart block 12 (3.5) 10 (3.3) 2 (2.6) 8 (3.6)
Other rhythm 6 (1.7) 3 (1) 2 (2.6) 1 (0.45)
Complications
Postoperative bleeding 347 (97) 46 (13) 301 (100) 36 (12) 11 (14) 25 (11) .47
Postoperative pacemaker 346 (97) 16 (4.6) 301 (100) 9 (3) 2 (2.6) 7 (3.1) .81
CABG, Coronary artery bypass grafting; SD, standard deviation. *Number of patients with data available.
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DEchocardiographic Follow-up
Aortic regurgitation. A total of 1728 echocardiographic
measurements of AR in 300 patients were available; 37FIGURE 1. Competing risks of outcomes. Prevalence of death (red) and
reoperation (blue) at each moment in time of patients in each of mutually
exclusive categories in the overall group. Parametric estimates enclosed
within 95% confidence limits show patient mortality (in red), reoperation
(in blue), and patients being alive and not undergoing reoperation (green).
1924 The Journal of Thoracic and Cardiovascular Surpatients had 1 or more echocardiographic measurements
of AR beyond 15 years. Temporal trend analyses yielded
only 1 phase. Figure 2 shows the temporal change in the per-
centages of patients in each AR grade over time. The per-
centage of patients in each grade of AR has changed
significantly over time. Although the percentage of patients
with AR grade 0 decreased sharply from 38% at 6 month to
20% by 15 years after the procedure and the percentage of
patients with grade 1þ remained the same at approximately
40% during the same time period, the percentage of pa-
tients with grade 2þ increased sharply from 19% to
31%. The percentage of patients with grade 3þ/4þ
increased gradually from 3.6% to 10% during the same
time period.
The subcoronary implantation group was associated with
a higher postoperative AR grade than the root replacement
group (P ¼ .0001) (Figure E2). The potential risk factors
associated with AR grade over time are shown in Table 4.
Younger age was associated with a higher grade of postop-
erative AR (P¼ .0007), and the effect was significant in the
subcoronary group (Figure E3). Furthermore, endocarditis
seems to be associated with a lower likelihood of postoper-
ative AR grade (P ¼ .0250).gery c November 2014
TABLE 3. Incremental risk factors for death and reoperation after
aortic valve implantation
Coefficient ± SD P value
Reliability*
(%)
Death
Early hazard phase
Agez 1.85  0.48 .0001 76
History of endocarditis 1.58  0.60 .0092 63
Renal disease 2.82  0.60 <.0001 91
Late hazard phase
Agez 1.33  0.21 <.0001 100
Renal disease 0.48  0.26 .041 59
Reoperation
Early hazard phase
Early date of surgeryy 0.97  0.25 <.0001 55
Renal disease 2.21  0.65 .001 66
Late hazard phase
Age 0.05  0.01 <.0001 100
Aortic ascending
aneurysm
0.91  0.26 .001 66
SD, Standard deviation. *Percentage of occurrence in 1000 bootstrapped models.
yLog (time interval [date of surgery January 3, 1987]). zExp[age/50], exponential
transformation.
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DAortic gradient. A total of 1609 echocardiographic mea-
surements of aortic gradient in 292 patients were available;
34 patients had 1 or more echocardiographic measurements
of aortic gradient beyond 15 years. Temporal trend analyses
yielded only 1 phase. Aortic gradient increases from 9.4
mmHg at 6months to 21.3 mmHg by 15 years after the pro-
cedure (Figure 3).
The subcoronary implantation group is associated with a
higher aortic gradient than the root replacement group
(P ¼ .0005). Younger age is associated with a higher aorticFIGURE 2. Temporal trend of AR after the procedure (grade 0 ¼ green,
grade 1þ ¼ blue, grade 2þ ¼ orange, grade 3þ/4þ ¼ red). Solid lines
represent percentage of patients (mean effect) in each grade at various
time points. Symbols represent crude estimates of grouped raw data without
regard to repeated measures and are presented to verify the model fitting.
AR, Aortic regurgitation.
The Journal of Thoracic and Cargradient (P < .0001) (Figure E4). Male donor gender
(P ¼ .0015) and concomitant mitral valve surgery
(P¼ .0011) were associated with higher aortic gradient dur-
ing follow-up. The potential risk factors associated with
aortic gradient over time are shown in Table 4.
Annulus diameter. A total of 1445 echocardiographic
measurements of annulus diameter in 284 patients were
available; 31 patients had 1 or more echocardiographic
measurements of annulus diameter beyond 15 years. Tem-
poral trend analyses yielded only 1 phase. Annulus diameter
increased from 21.9 mm at 6 months to 22.4 mm by 15 years
after the procedure. This increase was not statistically sig-
nificant (P ¼ .5460) (Figure E5).
There is a procedure effect on the annulus diameter, and
the root replacement technique is associated with a larger
annulus diameter (P < .0001) (Figure E6). Male donor
gender (P<.0047), male patient gender (P<.0001), and
higher allograft diameter (P < .0001) were associated
with larger annulus diameter during follow-up. The poten-
tial risk factors associated with annulus diameter over
time are shown in Table 4.
Left ventricular outflow tract diameter. A total of 1463
echocardiographic measurements of LVOT diameter in
286 patients were available; 32 patients had 1 or more echo-
cardiographic measurements of LVOT diameter beyond 15
years. Temporal trend analyses yielded only 1 phase. No
significant change in the LVOT diameter was observed
(P ¼ .6582) with a diameter of approximately 21.8 mm at
6 months and 22.0 mm at 15 years after the procedure
(Figure E7).
Male donor gender (P<.0001), aortic annulus aneurysm
(P ¼ .0011), and tricuspid aortic valve (P ¼ .0011) were
associated with larger LVOT diameter during follow-up.
Larger allograft diameter was associated with larger
LVOT diameter during follow-up. The potential risk factors
associated with LVOT diameter over time are shown in
Table 4.
Aortic diameter. A total of 1603 echocardiographic mea-
surements of aortic diameter in 294 patients were available;
34 patients had 1 or more echocardiographic measurements
of aortic diameter beyond 15 years. Temporal trend ana-
lyses yielded only 1 phase. Aortic diameter decreased
slightly from 34.3 mm at 6 months to 32.7 mm at 12 years
after the procedure. Although the decrease is statistically
significant (P<.0001), it may not be clinically significant
(Figure E8).
Male donor gender (P<.0001), calcified aortic annulus
(P ¼ .0061), preoperative AR (P< .0001), male patient
gender (P < .0001), and elective surgery (P ¼ .0106)
were associated with larger aortic diameter during follow-
up. Concomitant mitral valve surgery (P¼ .0496) was asso-
ciated with smaller aortic diameter during follow-up. The
potential risk factors associated with aortic diameter over
time are shown in Table 4.diovascular Surgery c Volume 148, Number 5 1925
TABLE 4. Preoperative risk factors associated with postoperative longitudinal echocardiographic measurement (results from the multivariate
analyses)
Echocardiographic measurement Factor Estimate ± SE P Reliability* (%)
AR Younger agey 1.44  0.42 .0007 90.0
Subcoronary AVR (vs root replacement) 2.48  0.33 <.0001 100
Endocarditis 0.70  0.31 .0250 73.2
Aortic gradient Male donor 0.17  0.05 .0015 98.0
Subcoronary AVR (vs root replacement) 0.21  0.06 .0005 100
Younger age 0.01  0.00 <.0001 93.5
Concomitant mitral valve surgery 0.25  0.12 .0445 91.5
Annulus diameter Larger allograft diameter 0.03  0.01 <.0001 96.7
Male donor 0.05  0.02 .0047 52.8
Male recipient 0.09  0.02 <.0001 58.3
Root replacement AVR (vs subcoronary) 0.07  0.02 <.0001 65.2
LVOT diameter Male gender 0.10  0.02 <.0001 84.2
Aortic annulus aneurysm 0.08  0.03 .0011 82.1
Tricuspid vs bicuspid aortic valve 0.08  0.03 .0011 67.3
Smaller allograft diameter 0.04  0.02 .0123 59.4
Aortic diameter Male donor gender 0.07  0.01 <.0001 99.3
Calcified aortic annulus 0.04  0.02 .0061 94.6
Preoperative AR 0.05  0.01 <.0001 78.8
Male patient gender 0.09  0.01 <.0001 65.7
Elective surgery 0.03  0.01 .0106 99.3
Concomitant mitral valve surgery 0.05  0.03 .0496 61.3
AR, Aortic regurgitation; AVR, aortic valve replacement; LVOT, left ventricular outflow tract; SE, standard error. *Percentage of occurrence of 1000 bootstrapped models. yLog
[age], logarithmic transformation.
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This study describes echocardiographic allograft valve
function over time in a cohort of patients whowere followed
prospectively after allograft aortic valve or root replace-
ment, illustrating the use of longitudinal data analysis for
the assessment of valve function over time.FIGURE 3. Solid lines are parametric estimates of mean aortic gradient
from nonlinear longitudinal mixed model and are enclosed within dashed
95% bootstrap percentile confidence bands, equivalent to 2 standard
deviations. Symbols represent crude estimates of grouped raw data
without regard to repeated measures and are presented to verify the model
fitting.
1926 The Journal of Thoracic and Cardiovascular SurClinical Outcomes
In our patient population, patient survival was 68% after
15 years of follow-up. Freedom from reoperation was 56%
after 15 years of follow-up. These results are comparable to
other series that report survival and freedom from reopera-
tion after allograft aortic valve and root replacement.15-19
Echocardiographic Outcomes
Among patients who underwent allograft aortic valve or
root replacement, 41% had 2þ or higher AR after 15 years
of follow-up. In patients in whom the complete aortic root
was implanted instead of the aortic valve in the subcoronary
position, the risk of higher AR grade was considerably
lower during follow-up. Furthermore, we observed higher
AR grades more often during follow-up in younger patients.
Although it has been shown that younger patients are at
higher risk of aortic allograft degeneration,20 the results
of our longitudinal echocardiographic study show that
younger patients are especially at risk for valve degenera-
tion when the subcoronary implantation technique is used
to implant the allograft.
The aortic gradient increased during follow-up from 9.4
mmHg at 6 months to 21.3 mmHg at 15 years. Comparable
to AR, the severity of aortic gradient during follow-up was
primarily influenced by younger patient age and the use of
the subcoronary implantation technique. Furthermore, male
donor gender was found to be significantly correlated with
higher aortic gradient during follow-up, which confirms thegery c November 2014
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immunologic reaction might be (partly) responsible for
valve failure.21 We have not observed major changes in
the annulus diameter, LVOT diameter, and aortic diameter
during follow-up.
The results of our longitudinal data analyses of echocar-
diographic valve function over time indicate that both
younger patient age and subcoronary implantation tech-
nique are important risk factors of allograft degeneration.
This is in accordance with previous studies that
investigated the clinical outcomes of patients with aortic
allograft.20,22-24
Methodology
The described methodology for the analyses of echocar-
diographic data was applied in the present study for several
reasons.
Longitudinal analyses versus time-to-event analyses.
The assessment of allograft valve performance (and other
valve substitutes) is complicated by several factors. First,
valves are implanted in patients who have a limited survival.
This creates a situation in which the risk of patient death
competes with valve durability. Second, valve failure is a
continuous process, not a hard end point. Therefore, time-
to-event analysis is inappropriate when assessing echocar-
diographic valve function, because it considers time of
follow-up as a continuous variable, whereas echocardio-
graphic data are usually available within a certain time
frame and often incomplete in 1 or more time frames. In
addition, those data consider valve dysfunction as an irre-
versible end point, whereas severity of valve dysfunction
(eg, AR) is often variable over time. Third, the means by
which echocardiographic follow-up is obtained may influ-
ence the results: Opportunistic versus standardized
follow-up, experience of the observer, and intervals be-
tween measurements all may cause bias. Finally, allograft
dysfunction may present in different ways, through regurgi-
tation, stenosis, or a combination, further complicating
valve performance analysis. The challenge in analyzing
longitudinal data is estimating the average pattern of
outcome over time and its variability in the group of pa-
tients. In addition, this average must take several sampling
characteristics into account (eg, censoring by death, un-
equal number of observations per patient, and different
follow-up intervals between observations).
In the present study, nonlinear longitudinal analysis tech-
niques were used to model the trend of various echocardio-
graphic measurements over time after the procedure. This
enabled us in turn to visualize the temporal trend of, for
example, each AR grade over time during follow-up. Clini-
cians can use such methods/graphs to determine how AR on
average develops over time after aortic allograft implanta-
tion. From a statistical perspective, the methods used are su-
perior and more informative compared with the methodsThe Journal of Thoracic and Carwhere repeated outcomes are dichotomized and analyzed
with actuarial methods as if they were events, such as
freedom from grade 1þ or 3þ AR after aortic valve sur-
gery.4,5 Assessing the trend of outcomes of interest and
identifying factors that influence these outcomes over
time can be of particular importance because they can
help the clinicians understand how a certain process
changes over time and thus can contribute to better
patient management (eg, by determining which patients
should be monitored more closely by their physicians and
at which time interval).
Although the use of time-to-event methods is less time-
and effort-consuming, these methods have major limita-
tions that may result in loss of information and wrong
statistical inferences that can lead to inadequate conclu-
sions, depending on the type of research question investi-
gated. Therefore, researchers should be encouraged in
taking into account the important characteristics of longitu-
dinally collected data when choosing the method of data
analysis.
Methods applied in the present study versus other
typical longitudinal analyses methods. Several longitudi-
nal analyses methods exist. Both linear and nonlinear struc-
tures can be used to analyze longitudinal data. In linear
methods, the degree of the outcome (y) is determined by
the degree of the input (x), which can be written as a
y ¼ ax þ b equation. An important characteristic of linear
methods is proportionality because there is a straight-line
relationship between the input value and the outcome.
Therefore, the behavior of linear methods can be fully pre-
dicted. However, the cardiovascular system is a complex
mechanical, chemical, and hemodynamic system in which
the processes are often related via a variety of mechanisms.
Therefore, these processes are often nonlinearly struc-
tured.25-27 Because the principle of proportionality may
not be valid, using linear methods may mean
simplification of the real process and therefore inaccurate
results and inferences. For example, the analyses of our
study show that aortic gradient is nonlinearly shaped.
During follow-up, the increase in aortic gradient mainly
occurred in the first 5 years after the surgery. If we had
modeled the aortic gradient as a linear process, we would
not be able to see the difference between how the aortic
gradient increased before and after this 5-year period. We
emphasize that not the data but the model determines the
shape of the relationship between the input and the
outcome. However, further validation is necessary to
confirm whether the nonlinear pattern is indeed the better
description of aortic gradient measurements.
The statistical methods that we applied are able to simul-
taneously model the risk factors for each time phase,
whereas in case when one has to use the usual longitudinal
methods to identify time-dependent risk factors, several
transformations of time along with their interaction effectsdiovascular Surgery c Volume 148, Number 5 1927
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difficult for the model to handle 40 or 50 covariates, and the
combination of them with different transformations of time
and the interpretation of such model would be difficult. The
statistical technique that has been illustrated in this study is
able to explicitly model the nonlinear trend and divides it in
different overlapping time phases, which in turn enable us
to simultaneously identify risk factors that are of particular
importance shortly after the procedure and those that are of
particular importance in the long-term. The approach of
longitudinal data analyses that is used in the present study
is also proposed by the 2008 guidelines for reporting mor-
tality and morbidity after cardiac valvular interventions.6
CONCLUSIONS
Both AR and stenosis increase over time after allograft
aortic valve or root replacement and are the most important
cause for allograft failure. Younger patient age and use of
the subcoronary implantation technique are associated
with increased regurgitation and stenosis. The analysis of
allograft valve function is complex and requires advanced
longitudinal models for adequate statistical analysis.
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ONLINE METHODS
Clinical Follow-up
All patients who receive a human tissue valve at the Erasmus University
Medical Center are enrolled in an ongoing prospective follow-up study.
They are followed systematically and actively through direct annual patient
contact by telephone. Clinical follow-up was based on the data obtained
from the total cohort of 356 aortic valve or root replacements that were per-
formed during the study period.
Valve-related complications and their consequences were defined ac-
cording to the 2008 guidelines for reporting morbidity and mortality after
cardiac valvular operationsE1 after confirmation of the event by the patient’s
treating physician. The database was frozen on September 30, 2010. Clin-
ical follow-upwas 95% complete (the ratio of total observed person time to
potential person time of follow-up to the closing date of the study).E2 The
mean clinical follow-up durationwas 10.8 years (median, 10.8 years; range,
0-23.9 years), with a total follow-up of 3842 patient years.
Echocardiographic Follow-up
Of the 356 aortic valve or root replacements that were performed during
the study period, 301 hospital survivors had 1 ormore standardized echocar-
diographic examinations. The analyses of echocardiographic valve function
over time were based on these 301 patients. Preoperative characteristics of
these patients in the ‘‘echocardiography cohort’’ are shown in Table 1.
A total of 1765 echocardiographic records were available for 301
patients. The mean echocardiographic follow-up was 5.6 years (median,
4.9 years; range, 1 week to 17 years) with 5% of the records collected after
15 years.
Postoperative transthoracic echocardiographic records were used to
assess the hemodynamic stability of the prosthesis. The severity of aortic
stenosis (millimeters of mercury) and AR were estimated according the
guidelines.E3,E4 AR was graded as 0 for no regurgitation, 1þ for mild,
2þ for moderate, 3þ for moderately severe, and 4þ for severe. Because
of low frequency in grade 4þ, this grade was collapsed together with 3þ
and is treated as 1 category. Also, annulus diameter (millimeters), LVOT
diameter (millimeters), and aortic diameter at the sinotubular junction
(millimeters) were recorded with the ‘‘leading-edge to leading-edge’’
method.E5 At least 1 echocardiographic follow-up was obtained in 95%
of eligible patients (301/318; 318 ¼ 352 minus 5 patients who are still
aged<16 years minus 25 patients who died in hospital or within the first
6 postoperative months minus 4 patients who had not yet reached the
6-month postoperative point in time). Reasons for not participating in the
remaining 5% of eligible patients were emigration, refusal, and bad quality
of echocardiography measurements (usually due to obesity).
The echocardiographic examinations were initially performed with
different echocardiographic equipment. Since January 1993, all examina-
tions are performed by 2 experienced technicians.
Statistical Analyses
Competing outcomes. The earliest occurrence after aortic allograft
surgery of one of the mutually exclusive outcomes (assumed absorbing
states) was identified: (1) reoperation or (2) death before reoperation.
The common interval of the analysis was the interval between the date of
reoperation and the earliest occurrence of one of these outcomes or the
duration to last follow-up date of being alive without any reoperation.
Freedom from each event was then estimated by the nonparametric product
limit method.E6
Variances of the estimates were based on the Greenwood formula.E6
The instantaneous risk (hazard function) for each competing event was
estimated by a parametric method.E7 Consequences of the independent
transition rates (hazard functions) from the category ‘‘alive, at risk’’ into
the event categories were calculated by integrating the parametric
equations.E8
Variable selection and risk factor analyses. Baseline char-
acteristics (Table 1) and perioperative characteristics (Table 2) were
screened for association with death, reoperation, postoperative AR, aortic
gradient, annulus diameter, LVOT diameter, and aortic diameter. In addi-
tion, year of surgery was included in the model as a potential risk factor.
Variable selection, with a P value criterion for retention of variables in the
model of .05, used bootstrap bagging (bootstrap aggregation).E9,E10 This was
a 4-step process. First, a patient was randomly selected from the original data
set to begin a new data set. The original data set continued to be sampled until
the new data set was 100% the size of the original. Second, risk factors were
identified using automated forward stepwise selection. Third, results of the
variable selection were stored. These 3 steps were repeated 1000 times.
Finally, the frequency of occurrence of variables related to groupmembership
was ascertained and indicated the reliability of each variable (aggregation
step). All variables with bootstrap reliability of 50% or greater were retained
in the guided analysis. Because of the limited capability of PROCNLMIXED
to exploremultivariable relations,we initially screened the variables using or-
dinary multivariable linear regression (PROC REG SAS; SAS Institute Inc,
Cary, NC) and the assumption of independence of observations with liberal
entry criteria (.2) and stay criteria (.12). This analysis was performed simply
to identify possible candidates for our repeated measurements model. These
candidates and their transformations, if any, were entered at once into our
model and then eliminated one by one until all variables remaining had a
P value of .05 or less. Parametric estimates of continuous postoperative
echocardiography measurements are accompanied by asymmetric 95%
confidence limits, comparable to2 standard errors, obtained by a bootstrap
percentile method.E11
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FIGURE E1. Instantaneous risks of death (red) and reoperation (blue)
(hazard function). Solid lines are parametric estimates enclosed within
95% confidence limits.
FIGURE E2. Predicted percentages of patients in AR grade 3þ/4þ strat-
ified by operative technique (subcoronary¼ red; root replacement¼ blue).
Symbols represent crude estimates of grouped raw data without regard to
repeated measures and are presented to verify the model fitting. AR, Aortic
regurgitation.
FIGURE E3. Fifteen-year predicted percentages of patients in AR grade
3þ/4þ by age, stratified by operative technique (subcoronary ¼ red; root
replacement ¼ blue). Symbols represent crude estimates of grouped raw
data without regard to repeated measures and are presented to verify the
model fitting. AR, Aortic regurgitation.
FIGURE E4. Fifteen-year predicted mean aortic gradient by age, strati-
fied by operative techniques (subcoronary¼ red; root replacement¼ blue).
FIGURE E5. Solid lines are parametric estimates of mean annulus diam-
eter from nonlinear longitudinal mixed model and are enclosed within
dashed 95% bootstrap percentile confidence bands, equivalent to 2 stan-
dard deviations. Symbols represent crude estimates of grouped raw data
without regard to repeated measures and are presented to verify the model
fitting.
FIGURE E6. Fifteen-year predicted mean of annulus diameter, stratified
by operative technique (subcoronary ¼ red; root replacement ¼ blue).
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FIGUREE7. Solid lines are parametric estimates of mean LVOT diameter
from nonlinear longitudinal mixed model and are enclosed within dashed
95% bootstrap percentile confidence bands, equivalent to 2 standard devi-
ations. Symbols represent crude estimates of grouped raw data without re-
gard to repeated measures and are presented to verify the model fitting.
LVOT, Left ventricular outflow tract.
FIGUREE8. Solid lines are parametric estimates of mean aortic diameter
from nonlinear longitudinal mixed model and are enclosed within dashed
95% bootstrap percentile confidence bands, equivalent to 2 standard devi-
ations. Symbols represent crude estimates of grouped raw data without re-
gard to repeated measures and are presented to verify the model fitting.
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